Indication: Sulfonamides are broad-spectrum antibacterial drugs, but because many common clinical pathogens are resistant to this class of drugs, they are only used for infections caused by sensitive bacteria and other sensitive pathogenic microorganisms. The indications of sulfadiazine (excluding the compound preparations of this class of drugs and trimethoprim) are: 1. Treatment and prevention of epidemic cerebrospinal meningitis caused by sensitive meningococci. 2. Combined with trimethoprim, it can treat otitis media and skin and soft tissue infections caused by Haemophilus influenzae, Streptococcus pneumoniae and other streptococci that are sensitive to it. 3. Astrocyte Nocardia. 4. An auxiliary drug for the treatment of chloroquine-resistant malignant malaria. 5. It is a second-choice drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis. 6. It is a second-choice drug for the treatment of neonatal inclusion conjunctivitis caused by Chlamydia trachomatis.

Indication: Sulfonamides are broad-spectrum antibacterial drugs, but because many common clinical pathogens are resistant to this class of drugs, they are only used for infections caused by sensitive bacteria and other sensitive pathogenic microorganisms. The indications of sulfadiazine (excluding the compound preparations of this class of drugs and trimethoprim) are: 1. Treatment and prevention of epidemic cerebrospinal meningitis caused by sensitive meningococci. 2. Combined with trimethoprim, it can treat otitis media and skin and soft tissue infections caused by Haemophilus influenzae, Streptococcus pneumoniae and other streptococci that are sensitive to it. 3. Astrocyte Nocardia. 4. An auxiliary drug for the treatment of chloroquine-resistant malignant malaria. 5. It is a second-choice drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis. 6. It is a second-choice drug for the treatment of neonatal inclusion conjunctivitis caused by Chlamydia trachomatis.

Indication: Sulfonamides are broad-spectrum antibacterial drugs, but because many common clinical pathogens are resistant to these drugs, they are only used for infections caused by sensitive bacteria and other sensitive pathogenic microorganisms. The indications of sulfadiazine (excluding the compound preparations of this drug and trimethoprim) are: 1. Treatment and prevention of epidemic cerebrospinal meningitis caused by sensitive meningococci. 2. Combined with trimethoprim, it can treat otitis media and skin and soft tissue infections caused by Haemophilus influenzae, Streptococcus pneumoniae and other streptococci that are sensitive to it. 3. Astrocyte Nocardia. 4. Auxiliary drug for the treatment of chloroquine-resistant malignant malaria. 5. It is the second-choice drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis. 6. It is the second-choice drug for the treatment of neonatal inclusion conjunctivitis caused by Chlamydia trachomatis.

Indication: This product is suitable for the following infections caused by sensitive bacteria: otitis media, sinusitis, pharyngitis, tonsillitis and other upper respiratory tract infections; bronchitis, pneumonia and other lower respiratory tract infections. Skin and soft tissue infections; simple genital infections caused by Chlamydia trachomatis; simple genital infections caused by non-multi-drug resistant gonococci (co-infection with Treponema burgdorferi must be excluded).

Indication: This product is suitable for the following infections caused by sensitive bacteria: 1. Respiratory tract infections: acute exacerbation of chronic bronchitis, bronchiectasis with infection, acute bronchitis and pneumonia, etc. 2. Urogenital system infections: acute cystitis, acute pyelonephritis, complicated urinary tract infection, acute exacerbation of chronic urinary tract infection, acute and chronic prostatitis, and urethritis or cervicitis caused by Neisseria gonorrhoeae (including those caused by enzyme-producing strains), etc. 3. Gastrointestinal bacterial infections: caused by Shigella, Salmonella, enterotoxigenic Escherichia coli, Aeromonas hydrophila, Vibrio parahaemolyticus, etc. 4. Infections of the abdominal cavity, bile duct, typhoid, etc. 5. Bone and joint infections. 6. Skin and soft tissue infections. 7. Systemic infections such as sepsis. 8. Other infections, such as sinusitis, otitis media, blepharitis, etc.

Indication: It is mainly used for viral pneumonia and bronchitis caused by respiratory syncytial virus (RSV). It is used for the prevention and treatment of epidemic hemorrhagic fever and Lassa fever. The early application of this product in the fever stage can shorten the fever period, alleviate kidney and blood vessel damage and poisoning symptoms. Topical application can treat herpes simplex virus keratitis.

Indication: It is mainly used for viral pneumonia and bronchitis caused by respiratory syncytial virus (RSV). It is used for the prevention and treatment of epidemic hemorrhagic fever and Lassa fever. The early application of this product in the fever stage can shorten the fever period, alleviate kidney and blood vessel damage and poisoning symptoms. Topical application can treat herpes simplex virus keratitis.

Indication: Prevent pneumococcal infection, especially respiratory infection. In principle, it is suitable for people over 2 years old, and is especially recommended for high-risk groups, such as the elderly over 65 years old, especially those living in nursing homes; those with weakened immune system; those who are frequently hospitalized (such as due to diabetes, chronic bronchitis, respiratory insufficiency, heart failure, and tobacco or alcohol dependence); and those with immunodeficiency (such as due to splenectomy, sickle cell anemia, and nephrotic syndrome).

Indication: 1. This product is used for infants aged 3 months to 2 years, and children aged 2 years to 5 years who have not been vaccinated with this vaccine (please refer to [Precautions] for high-risk groups). Recommended routine immunization program: basic immunization at 3, 4, and 5 months of age, and booster immunization at 12 to 15 months of age. 2. This product is used for active immunization of infants and young children to prevent invasive diseases caused by the 7 serotypes of pneumococci included in this vaccine (4, 6B, 9V, 14, 18C, 19F and 23F). Pneumococcus is a common cause of invasive infections (including sepsis, meningitis, bacteremic pneumonia and bacteremia), as well as upper respiratory tract infections such as pneumonia. Infants and young children under 2 years old are at the highest risk of invasive diseases. 3. The use of this vaccine should take into account the differences in the serotypes of pneumococcal diseases caused by different regions and the impact of invasive diseases on different age groups. This vaccine does not prevent infections caused by other types of pneumococci other than the serotypes included in the vaccine, nor does it prevent invasive infections caused by other microorganisms.

Indication: This product is suitable for the following mild and moderate infections caused by sensitive bacteria: 1. Respiratory system infections: acute bronchitis, acute exacerbation of chronic bronchitis, diffuse bronchiolitis, bronchiectasis complicated with infection, pneumonia, tonsillitis (peritonsillar abscess); 2. Urinary system infections: pyelonephritis, complicated urinary tract infection, etc.; 3. Reproductive system infections: acute prostatitis, acute epididymitis, uterine cavity infection, uterine adnexitis, pelvic inflammatory disease (metronidazole can be used in combination when anaerobic bacteria infection is suspected); 4. Skin and soft tissue infections: infectious impetigo, cellulitis, lymphangitis (adenitis), subcutaneous abscess, perianal abscess, etc.; 5. Intestinal infections: bacterial dysentery, infectious enteritis, Salmonella enteritis, typhoid and paratyphoid; 6. Various infections in patients with sepsis, neutropenia and immunodeficiency; 7. Other infections: mastitis, trauma, burns and postoperative wound infection, abdominal infection (combined with metronidazole when necessary), cholecystitis, cholangitis, bone and joint infection, and ENT infection, etc.